Freitag Gregory Gene
Insider CIK 1492710 · PDSB Director · ZVSA Director · AXGN General Counsel & SVP BD, Director · PBIO Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PDSB PDS Biotechnology Corp | A Award deriv | 2026-01-12 | 2026-03-03 | 54,876 | — | $0 | 54,876 | SEC↗ |
| ZVSA ZyVersa Therapeutics, Inc. | A Award deriv | 2025-07-11 | 2025-07-15 | 11,066 | — | $0 | 11,066 | SEC↗ |
| PDSB PDS Biotechnology Corp | A Award deriv | 2025-06-11 | 2025-06-11 | 22,700 | — | $0 | 22,700 | SEC↗ |
| PDSB PDS Biotechnology Corp | P Buy deriv | 2025-02-28 | 2025-03-03 | 15,060 | — | $0 | 15,060 | SEC↗ |
| PDSB PDS Biotechnology Corp | P Buy | 2025-02-28 | 2025-03-03 | 15,060 | $1.66 | $25.0K | 61,213 | SEC↗ |
| PDSB PDS Biotechnology Corp | A Award deriv | 2024-06-24 | 2024-06-25 | 9,000 | — | $0 | 9,000 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise deriv | 2024-06-04 | 2024-06-06 | 11,904 | — | $0 | 0 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise | 2024-06-04 | 2024-06-06 | 11,904 | — | $0 | 283,498 | SEC↗ |
| AXGN Axogen, Inc. | S Sale | 2024-03-07 | 2024-03-08 | 25,000 | $9.00 | $225.0K | 271,594 | SEC↗ |
| AXGN Axogen, Inc. | A Award deriv | 2023-09-01 | 2023-09-07 | 11,904 | — | $0 | 11,904 | SEC↗ |
| AXGN Axogen, Inc. | A Award deriv | 2023-09-01 | 2023-09-07 | 20,436 | — | $0 | 20,436 | SEC↗ |
| PDSB PDS Biotechnology Corp | A Award deriv | 2023-07-14 | 2023-07-17 | 9,000 | — | $0 | 9,000 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise deriv | 2023-06-01 | 2023-06-05 | 6,459 | — | $0 | 0 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise | 2023-06-01 | 2023-06-05 | 6,459 | — | $0 | 296,594 | SEC↗ |
| AXGN Axogen, Inc. | S Sale | 2023-06-01 | 2023-06-05 | 29,480 | $8.74 | $257.7K | 290,135 | SEC↗ |
| AXGN Axogen, Inc. | S Sale | 2023-06-01 | 2023-06-05 | 12,500 | $8.65 | $108.1K | 319,615 | SEC↗ |
| ZVSA ZyVersa Therapeutics, Inc. | A Award deriv | 2023-05-24 | 2024-07-18 | 132 | — | $0 | 132 | SEC↗ |
| AXGN Axogen, Inc. | S Sale | 2023-05-23 | 2023-05-24 | 4,640 | $9.26 | $43.0K | 332,115 | SEC↗ |
| AXGN Axogen, Inc. | S Sale | 2023-05-23 | 2023-05-24 | 2,828 | $9.17 | $25.9K | 336,755 | SEC↗ |
| AXGN Axogen, Inc. | S Sale | 2022-11-14 | 2022-11-16 | 13,000 | $12.74 | $165.6K | 339,583 | SEC↗ |
| AXGN Axogen, Inc. | S Sale | 2022-11-08 | 2022-11-10 | 13,000 | $12.50 | $162.5K | 352,583 | SEC↗ |
| AXGN Axogen, Inc. | S Sale | 2022-08-10 | 2022-08-11 | 8,886 | $9.70 | $86.2K | 365,583 | SEC↗ |
| AXGN Axogen, Inc. | S Sale | 2022-08-08 | 2022-08-08 | 13,046 | $10.37 | $135.3K | 374,469 | SEC↗ |
| AXGN Axogen, Inc. | S Sale | 2022-08-04 | 2022-08-08 | 24,000 | $10.64 | $255.4K | 387,515 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise deriv | 2022-07-25 | 2022-07-26 | 83,000 | — | $0 | 0 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise | 2022-07-25 | 2022-07-26 | 83,000 | $3.38 | $280.5K | 441,811 | SEC↗ |
| AXGN Axogen, Inc. | F Tax w/h | 2022-07-25 | 2022-07-26 | 30,296 | $9.26 | $280.5K | 411,515 | SEC↗ |
| PDSB PDS Biotechnology Corp | A Award deriv | 2022-06-28 | 2022-06-29 | 9,000 | — | $0 | 9,000 | SEC↗ |
| AXGN Axogen, Inc. | A Award deriv | 2022-06-01 | 2022-06-03 | 11,811 | — | $0 | 11,811 | SEC↗ |
| AXGN Axogen, Inc. | A Award deriv | 2022-06-01 | 2022-06-03 | 6,459 | — | $0 | 6,459 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise deriv | 2022-06-01 | 2022-06-03 | 3,036 | — | $0 | 0 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise | 2022-06-01 | 2022-06-03 | 3,036 | — | $0 | 358,811 | SEC↗ |
| PDSB PDS Biotechnology Corp | A Award deriv | 2021-06-17 | 2021-06-17 | 9,000 | — | $0 | 9,000 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise deriv | 2021-06-17 | 2021-06-21 | 9,250 | — | $0 | 0 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise | 2021-06-17 | 2021-06-21 | 9,250 | $19.17 | $177.3K | 364,556 | SEC↗ |
| AXGN Axogen, Inc. | F Tax w/h | 2021-06-17 | 2021-06-21 | 8,781 | $20.92 | $183.7K | 355,775 | SEC↗ |
| PDSB PDS Biotechnology Corp | P Buy | 2021-06-15 | 2021-06-17 | 5,882 | $8.50 | $50.0K | 46,153 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise deriv | 2021-06-04 | 2021-06-08 | 24,000 | $3.67 | $88.1K | 0 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise | 2021-06-04 | 2021-06-08 | 24,000 | $3.67 | $88.1K | 355,306 | SEC↗ |
| AXGN Axogen, Inc. | A Award deriv | 2021-06-01 | 2021-06-03 | 6,030 | — | $0 | 6,030 | SEC↗ |
| AXGN Axogen, Inc. | A Award deriv | 2021-06-01 | 2021-06-03 | 3,036 | — | $0 | 3,036 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise deriv | 2021-05-26 | 2021-05-28 | 22,954 | $3.67 | $84.2K | 0 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise deriv | 2021-05-26 | 2021-05-28 | 9,000 | $5.09 | $45.8K | 0 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise deriv | 2021-05-26 | 2021-05-28 | 15,000 | $5.45 | $81.8K | 0 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise deriv | 2021-05-26 | 2021-05-28 | 50,000 | $8.95 | $447.5K | 0 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise deriv | 2021-05-26 | 2021-05-28 | 6,000 | $5.45 | $32.7K | 0 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise | 2021-05-26 | 2021-05-28 | 15,000 | $5.45 | $81.8K | 281,306 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise | 2021-05-26 | 2021-05-28 | 22,954 | $3.67 | $84.2K | 251,306 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise | 2021-05-26 | 2021-05-28 | 9,000 | $5.09 | $45.8K | 260,306 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise | 2021-05-26 | 2021-05-28 | 6,000 | $5.45 | $32.7K | 266,306 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise | 2021-05-26 | 2021-05-28 | 50,000 | $8.95 | $447.5K | 331,306 | SEC↗ |
| AXGN Axogen, Inc. | S Sale | 2021-02-25 | 2021-03-01 | 24,000 | $22.06 | $529.4K | 228,352 | SEC↗ |
| AXGN Axogen, Inc. | F Tax w/h | 2021-02-17 | 2021-02-18 | 1,032 | $18.70 | $19.3K | 251,113 | SEC↗ |
| AXGN Axogen, Inc. | F Tax w/h | 2021-02-17 | 2021-02-18 | 545 | $18.70 | $10.2K | 252,352 | SEC↗ |
| AXGN Axogen, Inc. | A Award | 2021-02-16 | 2021-02-18 | 1,784 | — | $0 | 252,897 | SEC↗ |
| AXGN Axogen, Inc. | A Award | 2021-02-16 | 2021-02-18 | 3,377 | — | $0 | 252,145 | SEC↗ |
| AXGN Axogen, Inc. | S Sale | 2020-12-29 | 2020-12-30 | 916 | $17.81 | $16.3K | 248,345 | SEC↗ |
| AXGN Axogen, Inc. | A Award | 2020-12-27 | 2020-12-30 | 2,300 | — | $0 | 249,261 | SEC↗ |
| AXGN Axogen, Inc. | S Sale | 2020-12-21 | 2020-12-22 | 379 | $16.42 | $6.2K | 245,076 | SEC↗ |
| AXGN Axogen, Inc. | A Award | 2020-12-18 | 2020-12-22 | 925 | — | $0 | 245,455 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise deriv | 2020-09-15 | 2020-09-17 | 4,046 | — | $0 | 22,954 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise deriv | 2020-09-15 | 2020-09-17 | 9,000 | — | $0 | 24,000 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise | 2020-09-15 | 2020-09-17 | 13,046 | $3.67 | $47.9K | 244,530 | SEC↗ |
| PDSB PDS Biotechnology Corp | A Award deriv | 2020-06-23 | 2020-06-25 | 9,000 | — | $0 | 9,000 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise deriv | 2020-05-29 | 2020-06-01 | 125,000 | — | $0 | 0 | SEC↗ |
| AXGN Axogen, Inc. | M Exercise | 2020-05-29 | 2020-06-01 | 125,000 | $3.50 | $437.5K | 231,484 | SEC↗ |
| AXGN Axogen, Inc. | A Award deriv | 2020-03-16 | 2020-03-18 | 24,000 | — | $0 | 24,000 | SEC↗ |
| AXGN Axogen, Inc. | A Award deriv | 2020-03-16 | 2020-03-18 | 12,000 | — | $0 | 12,000 | SEC↗ |
| AXGN Axogen, Inc. | F Tax w/h | 2020-02-18 | 2020-02-20 | 1,002 | $14.68 | $14.7K | 105,230 | SEC↗ |
| AXGN Axogen, Inc. | A Award | 2020-02-18 | 2020-02-20 | 3,377 | — | $0 | 106,232 | SEC↗ |
| AXGN Axogen, Inc. | A Award | 2020-02-18 | 2020-02-20 | 1,783 | — | $0 | 107,013 | SEC↗ |
| AXGN Axogen, Inc. | F Tax w/h | 2020-02-18 | 2020-02-20 | 529 | $14.68 | $7.8K | 106,484 | SEC↗ |
| PDSB PDS Biotechnology Corp | A Award | 2020-02-14 | 2020-02-19 | 38,400 | $1.30 | $49.9K | 40,271 | SEC↗ |
| AXGN Axogen, Inc. | A Award | 2019-12-18 | 2019-12-20 | 1,850 | — | $0 | 102,110 | SEC↗ |
| AXGN Axogen, Inc. | F Tax w/h | 2019-12-18 | 2019-12-20 | 567 | $16.73 | $9.5K | 101,543 | SEC↗ |
| PDSB PDS Biotechnology Corp | A Award deriv | 2019-06-28 | 2019-07-01 | 9,000 | — | $0 | 9,000 | SEC↗ |
| AXGN AxoGen, Inc. | A Award | 2019-02-15 | 2019-02-19 | 3,377 | $17.57 | $59.3K | 100,260 | SEC↗ |
| AXGN AxoGen, Inc. | A Award deriv | 2018-12-27 | 2018-12-31 | 18,500 | — | $0 | 18,500 | SEC↗ |
| AXGN AxoGen, Inc. | A Award deriv | 2018-12-27 | 2018-12-31 | 4,600 | — | $0 | 4,600 | SEC↗ |
| AXGN AxoGen, Inc. | S Sale | 2018-11-30 | 2018-12-04 | 45,000 | $33.00 | $1.49M | 95,865 | SEC↗ |
| AXGN AxoGen, Inc. | S Sale | 2018-11-15 | 2018-11-15 | 20,000 | $32.25 | $645.0K | 140,865 | SEC↗ |
| AXGN AxoGen, Inc. | M Exercise deriv | 2018-03-21 | 2018-03-23 | 16,000 | — | $0 | 0 | SEC↗ |
| AXGN AxoGen, Inc. | M Exercise deriv | 2018-03-21 | 2018-03-23 | 15,000 | — | $0 | 0 | SEC↗ |
| AXGN AxoGen, Inc. | M Exercise | 2018-03-21 | 2018-03-23 | 15,000 | $4.81 | $72.2K | 162,739 | SEC↗ |
| AXGN AxoGen, Inc. | F Tax w/h | 2018-03-21 | 2018-03-23 | 1,022 | $38.50 | $39.3K | 147,739 | SEC↗ |
| AXGN AxoGen, Inc. | M Exercise | 2018-03-21 | 2018-03-23 | 16,000 | $2.46 | $39.4K | 148,761 | SEC↗ |
| AXGN AxoGen, Inc. | F Tax w/h | 2018-03-21 | 2018-03-23 | 1,874 | $38.50 | $72.1K | 160,865 | SEC↗ |
| AXGN AxoGen, Inc. | M Exercise deriv | 2018-03-01 | 2018-03-05 | 36,000 | — | $0 | 0 | SEC↗ |
| AXGN AxoGen, Inc. | M Exercise | 2018-03-01 | 2018-03-05 | 36,000 | $2.74 | $98.6K | 135,666 | SEC↗ |
| AXGN AxoGen, Inc. | F Tax w/h | 2018-03-01 | 2018-03-05 | 2,905 | $33.95 | $98.6K | 132,761 | SEC↗ |
| AXGN AxoGen, Inc. | M Exercise deriv | 2017-12-30 | 2017-03-14 | 23,000 | — | $0 | 69,000 | SEC↗ |
| AXGN AxoGen, Inc. | A Award deriv | 2017-12-18 | 2017-12-20 | 3,700 | — | $0 | 3,700 | SEC↗ |
| AXGN AxoGen, Inc. | A Award deriv | 2017-12-18 | 2017-12-20 | 22,100 | — | $0 | 22,100 | SEC↗ |
| AXGN AxoGen, Inc. | M Exercise deriv | 2017-09-25 | 2017-09-27 | 10,000 | — | $0 | 36,000 | SEC↗ |
| AXGN AxoGen, Inc. | M Exercise | 2017-09-25 | 2017-09-27 | 10,000 | $2.74 | $27.4K | 101,116 | SEC↗ |
| AXGN AxoGen, Inc. | F Tax w/h | 2017-09-25 | 2017-09-27 | 1,450 | $18.90 | $27.4K | 99,666 | SEC↗ |
| AXGN AxoGen, Inc. | M Exercise deriv | 2017-08-27 | 2017-08-29 | 23,000 | — | $0 | 46,000 | SEC↗ |
| AXGN AxoGen, Inc. | F Tax w/h | 2017-08-27 | 2017-08-29 | 3,785 | $16.65 | $63.0K | 91,116 | SEC↗ |
| AXGN AxoGen, Inc. | M Exercise | 2017-08-27 | 2017-08-29 | 23,000 | $2.74 | $63.0K | 94,901 | SEC↗ |
| AXGN AxoGen, Inc. | M Exercise | 2016-12-30 | 2017-03-14 | 23,000 | $2.74 | $63.0K | 71,901 | SEC↗ |
| AXGN AxoGen, Inc. | A Award deriv | 2016-12-29 | 2017-01-03 | 50,000 | — | $0 | 50,000 | SEC↗ |
| AXGN AxoGen, Inc. | A Award deriv | 2016-05-26 | 2016-05-31 | 6,000 | — | $0 | 6,000 | SEC↗ |
| AXGN AxoGen, Inc. | A Award deriv | 2016-05-26 | 2016-05-31 | 15,000 | — | $0 | 15,000 | SEC↗ |
| AXGN AxoGen, Inc. | A Award deriv | 2015-12-28 | 2016-05-31 | 9,000 | — | $0 | 9,000 | SEC↗ |
| AXGN AxoGen, Inc. | A Award deriv | 2015-12-28 | 2015-12-30 | 9,000 | — | $0 | 9,000 | SEC↗ |
| AXGN AxoGen, Inc. | A Award deriv | 2015-08-06 | 2016-05-31 | 83,000 | — | $0 | 83,000 | SEC↗ |
| AXGN AxoGen, Inc. | A Award deriv | 2015-08-06 | 2015-12-30 | 83,000 | — | $0 | 83,000 | SEC↗ |
| AXGN AxoGen, Inc. | A Award | 2015-02-10 | 2015-02-12 | 4,800 | $2.75 | $13.2K | 48,902 | SEC↗ |
| AXGN AxoGen, Inc. | A Award deriv | 2014-12-29 | 2014-12-31 | 33,000 | — | $0 | 308,000 | SEC↗ |
| AXGN AxoGen, Inc. | A Award deriv | 2014-12-29 | 2014-12-31 | 27,000 | — | $0 | 275,000 | SEC↗ |
| AXGN AxoGen, Inc. | A Award deriv | 2014-10-01 | 2014-10-10 | 16,000 | — | $0 | 248,000 | SEC↗ |
| AXGN AxoGen, Inc. | P Buy | 2014-06-03 | 2014-06-04 | 200 | $2.34 | $468 | 29,518 | SEC↗ |
| AXGN AxoGen, Inc. | P Buy | 2014-06-02 | 2014-06-04 | 5,000 | $2.45 | $12.3K | 29,318 | SEC↗ |
| AXGN AxoGen, Inc. | A Award deriv | 2014-01-02 | 2014-01-06 | 15,000 | — | $0 | 232,000 | SEC↗ |
| AXGN AxoGen, Inc. | A Award | 2014-01-02 | 2014-01-06 | 6,250 | — | $0 | 38,901 | SEC↗ |
| AXGN AxoGen, Inc. | P Buy | 2013-08-14 | 2013-08-15 | 8,334 | $3.00 | $25.0K | 32,652 | SEC↗ |
| PBIO PRESSURE BIOSCIENCES INC | J Other | 2012-04-05 | 2012-04-10 | 4,385 | — | $0 | 47,048 | SEC↗ |
| AXGN AxoGen, Inc. | P Buy | 2011-12-30 | 2012-01-03 | 9,318 | $2.40 | $22.4K | 24,318 | SEC↗ |